The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Corero Hires Former CML Finance Director

Mon, 27th Apr 2020 13:52

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Corero Network Security PLC - defence against denial of service cyber attacks - Hires Lionel Chmilewsky as chief executive officer designate, starting on Friday. Chmilewsky will take over as CEO from Ashley Stephenson on July 1. Stephenson will move over to chief technology officer, remaining on the board. Chmilewsky was most recently CEO of Cambridge Broadband Networks Ltd. Corero also hires Neil Pritchard as finance director, from Friday. Pritchard was financial director at CML Microsystems PLC. Andrew Miller steps down as chief financial officer of Corero but remains as a non-executive director. CML had announced Pritchard's departure back in November, saying at the time he had resigned "to pursue other career opportunities". It later said Non-Executive Chair Nigel Clark would take on the additional role of finance director while it reviews its finance function.

----------

Carclo PLC - engineering - Promotes Non-Executive Director Joe Oatley to chair, effective immediately. Oatley is the former CEO of industrial services firm Cape PLC. He joined Carclo board in July 2018 and also is on the board of construction company Wates Group Ltd. Carclo said that since Mark Rollins left as chair on March 24, the Covid-19 crisis has delayed the search for a permanent replacement, so Oatley agreed to be chair until a longer-term replacement is found. "The board believes that it is essential to have a chairman in place given the current challenging market environment and the need to secure a long-term financing position for the group," Carclo said.

----------

Aston Martin Lagonda Global Holdings PLC - car maker - Michael de Picciotto joins board immediately as representative non-executive director of Yew Tree Consortium. De Picciotto is vice chair of supervisory board of Engel & Volkers AG. He has waived his board fee for 2020. Yew Tree is a company controlled by lead investor and new Aston Martin chair Lawrence Stroll.

----------

ECO Animal Health Group PLC - livestock vaccines - Hires Frank Armstrong as non-executive director. Armstrong already is non-executive chair of Faron Pharmaceutical Oy and Caldan Therapeutics Ltd.

----------

Tristel PLC - infection prevention - Hires Isabel Napper as non-executive director. Napper was a partner at law firm Mills & Reeve and currently is a non-executive director of SDI Group PLC.

----------

Vaalco Energy Inc - exploration and development in West Africa - William Thomas resigns as president and from board with immediate effect. His "resignation was not in connection with any disagreement with the company on any matter relating to the company's operations, policies or practices," it notes.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Aug 2021 11:43

Faron doses first patient in Covid-19 treatment trial

(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals announced on Wednesday that the first patient has been dosed in the phase 2 and 3 'HIBISCUS' trial, assessing 'Traumakine', or intravenous interferon beta-1a, as a first-line treatment for hospitalised Covid-19 patients.

Read more
25 Aug 2021 11:38

IN BRIEF: Faron Pharmaceuticals begins study of new Covid treatment

IN BRIEF: Faron Pharmaceuticals begins study of new Covid treatment

Read more
19 Aug 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jun 2021 10:33

Faron Pharmaceuticals granted US patent for cancer immunotherapy drug

Faron Pharmaceuticals granted US patent for cancer immunotherapy drug

Read more
3 Jun 2021 19:20

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

Read more
3 Jun 2021 14:47

New research supports mode of action in Faron's 'MATINS' study

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced the publication of research supporting the immunotherapeutic blockade of 'Clever-1' to activate anti-tumour immune responses in advanced cancer patients on Thursday.

Read more
17 May 2021 17:49

TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch

TRADING UPDATES: Wey takeover edges closer; Acorn in strategy switch

Read more
17 May 2021 10:13

Faron Pharmaceuticals reports 'promising' data from drug study

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced "promising" new data from its ongoing bexmarilimab 'MATINS' study on Monday, reporting combined headline data from 141 evaluable patients enrolled in the completed first part and the ongoing second part of the study.

Read more
14 May 2021 12:29

Faron Pharmaceuticals gets US rights to patent related to Traumakine

Faron Pharmaceuticals gets US rights to patent related to Traumakine

Read more
14 May 2021 11:18

Faron Pharmaceuticals signs US sublicence agreement

(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has signed a sublicence agreement for the rights to United States patent US9,376,478, it announced on Friday, which currently extends to 2033.

Read more
23 Apr 2021 15:43

EXECUTIVE CHANGES: Universe Group hires CFO as new CEO also joins

EXECUTIVE CHANGES: Universe Group hires CFO as new CEO also joins

Read more
16 Apr 2021 14:54

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
25 Mar 2021 14:49

TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout

TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout

Read more
22 Mar 2021 11:22

AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement

AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement

Read more
22 Mar 2021 09:32

Faron Pharmaceuticals shares boosted by positive data on cancer drug

Faron Pharmaceuticals shares boosted by positive data on cancer drug

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.